Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
Discover Oncology|July 8, 2025
Identification of disulfidptosis-related prognostic biomarkers associated with CD4 + and CD8 + T cells infiltration for sarcoma by integrating bioinformatic analysis and experimental validationWenliang Tan, Xi Zhou, Ting Wang, et al.International Heart Journal|November 30, 2022
MicroRNA-22-3p Restrains the Proliferation, Phenotypic Transformation, and Migration of Vascular Smooth Muscle Cells by Manipulating TOMM40Wenliang Tan, Yong Yang, Huogeng Bao, et al.Cancer Medicine|November 2, 2019
Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinomaSicong Zhu, Xuelian Huang, Kelin Zhang, et al.Journal of Cancer|July 2, 2019
miR-1226-3p Promotes Sorafenib Sensitivity of Hepatocellular Carcinoma via Downregulation of DUSP4 ExpressionXianqing Chen, Wenliang Tan, Wenxin Li, et al.Surgical Endoscopy|April 9, 2017
Laparoscopic liver re-resection is feasible for patients with posthepatectomy hepatocellular carcinoma recurrence: a propensity score matching studyKairui Liu, Yajin Chen, Xiaolin Wu, et al.International Journal of Biological Macromolecules|September 4, 2025
Delactylation of H3K9 by Sirtuin6 inhibits MGMT transcription and reverses temozolomide resistance in glioblastomaLi Zou, Zhimin Liu, Luyao Peng, et al.Oncology Research|March 10, 2017
Inhibition of MMP-2 Expression Enhances the Antitumor Effect of Sorafenib in Hepatocellular Carcinoma by Suppressing the PI3K/AKT/mTOR PathwayWenliang Tan, Sicong Zhu, Jun Cao, et al.Cancer Management and Research|October 6, 2018
Low expression of VSIG4 is associated with poor prognosis in hepatocellular carcinoma patients with hepatitis B infectionSicong Zhu, Wenliang Tan, Wenxin Li, et al.Journal of Advanced Research|February 1, 2023
GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinomaWenliang Tan, Kelin Zhang, Xinming Chen, et al.Annals of Translational Medicine|February 8, 2021
miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1Wenliang Tan, Zhirong Lin, Xianqing Chen, et al.Pageof 5